RITUXAN®
RITUXAN® (rituximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, thereby helping to protect healthy cells from damage. Specifically, it is a CD20-directed cytolytic antibody used for a variety of lymphomas, leukemias, and inflammatory conditions. Although RITUXAN may be used to treat cancer, it is not chemotherapy.
Other biosimilar brands of Rituximab include RUXIENCE (rituximab-pvvr) and TRUXIMA (rituximab-abbs).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
